We are live on ! Find out more
DGX icon

Quest Diagnostics

485 hedge funds and large institutions have $8.81B invested in Quest Diagnostics in 2014 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 158 increasing their positions, 199 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more funds holding in top 10

Funds holding in top 10: 78 (+1)

1% more capital invested

Capital invested by funds: $8.72B → $8.81B (+$84.4M)

1.01% less ownership

Funds ownership: 102.83%101.82% (-1%)

2% less funds holding

Funds holding: 496485 (-11)

20% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 45

21% less repeat investments, than reductions

Existing positions increased: 158 | Existing positions reduced: 199

41% less call options, than puts

Call options by funds: $122M | Put options by funds: $206M

Holders
485
Holders Change
-11
Holders Change %
-2.22%
% of All Funds
14.07%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.23%
New
36
Increased
158
Reduced
199
Closed
45
Calls
$122M
Puts
$206M
Net Calls
-$83.5M
Net Calls Change
-$136M
Name Holding Trade Value Shares
Change
Change in
Stake
New York State Common Retirement Fund
51
New York State Common Retirement Fund
New York
$32M +$4.62M +74,947 +17%
Invesco
52
Invesco
Georgia
$30.7M +$270K +4,375 +0.9%
TG
53
TCW Group
California
$30.4M +$1.77M +28,769 +6%
CCM
54
Camber Capital Management
Massachusetts
$30.3M -$37M -600,000 -55%
NTC
55
North Tide Capital
Massachusetts
$30.3M -$30.8M -500,000 -50%
Westfield Capital Management
56
Westfield Capital Management
Massachusetts
$30.1M +$30.6M +496,300 New
MSA
57
Mason Street Advisors
Wisconsin
$30M +$301K +4,882 +1%
RFC
58
Russell Frank Company
Washington
$28.4M +$2.58M +41,812 +10%
HA
59
Heartland Advisors
Wisconsin
$28.3M -$191K -3,106 -0.7%
KG
60
Killen Group
Pennsylvania
$28.3M +$61.6K +1,000 +0.2%
RJA
61
Raymond James & Associates
Florida
$28.1M +$2.67M +43,293 +10%
Charles Schwab
62
Charles Schwab
California
$26.6M +$986K +16,005 +4%
Pzena Investment Management
63
Pzena Investment Management
New York
$26.1M -$86.3K -1,400 -0.3%
Prudential Financial
64
Prudential Financial
New Jersey
$25.3M -$583K -9,458 -2%
TCIM
65
TIAA CREF Investment Management
New York
$24.4M -$751K -12,187 -3%
Robeco Institutional Asset Management
66
Robeco Institutional Asset Management
Netherlands
$23.6M +$1.02M +16,500 +4%
CC
67
Chubb Corp
New Jersey
$22.5M
BlackRock
68
BlackRock
New York
$22.4M -$2.32M -37,596 -9%
Sumitomo Mitsui Trust Group
69
Sumitomo Mitsui Trust Group
Japan
$22.1M +$211K +3,432 +1%
SOMRS
70
State of Michigan Retirement System
Michigan
$21.8M +$5.3M +86,000 +32%
State of New Jersey Common Pension Fund D
71
State of New Jersey Common Pension Fund D
New Jersey
$21.5M -$3.7M -60,000 -14%
PTC
72
Philadelphia Trust Company
Pennsylvania
$21.2M -$253K -4,102 -1%
Morgan Stanley
73
Morgan Stanley
New York
$21.2M +$3.45M +55,986 +19%
AI
74
Ariel Investments
Illinois
$21.2M -$248K -4,018 -1%
Allianz Asset Management
75
Allianz Asset Management
Germany
$20.8M +$8.76M +142,186 +71%

DGX Hedge Fund Activity: Q3 2014 in Review

485 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q3 2014, worth a combined $8.81B — up 0.97% from $8.72B a quarter earlier.

Sellers outnumbered buyers: 45 funds closed out of DGX and 36 opened new positions — a net loss of 9 holders — while 199 trimmed existing stakes and 158 added.

The largest buyer was Fidelity International, opening a new position worth an estimated $119M. The largest seller was Norges Bank, cutting an estimated $74.9M.

  • 485 institutional investors held Quest Diagnostics (DGX) as of Q3 2014, down from 496 in Q2 2014.
  • Funds reported $8.81B of Quest Diagnostics stock for Q3 2014, up 0.97% quarter-over-quarter.
  • 36 funds opened new Quest Diagnostics positions in Q3 2014 and 45 closed out, a net change of -9 holders.
  • The largest Quest Diagnostics buyer in Q3 2014 was Fidelity International, an estimated $119M added.
  • The largest Quest Diagnostics seller in Q3 2014 was Norges Bank, an estimated $74.9M sold.

Based on aggregated 13F filings for Q3 2014.